Eastern Equine Encephalitis in Florida: One of the Deadliest Mosquito Diseases in the U.S.

Florida is among the top states for Eastern Equine Encephalitis cases in the United States, consistently reporting cases annually. EEE is most active in Florida during late summer and fall (August–October) when bridge vector populations peak. Northern and central Florida counties have historically seen the most frequent outbreaks, but cases have been confirmed in Broward and Palm Beach counties. Florida's year-round warm temperatures and extensive freshwater swamp and wetland habitat (particularly the Everglades and connected wetlands) support the enzootic transmission cycle among birds throughout the year.

Eastern Equine Encephalitis has one of the highest case fatality rates of any U.S. mosquito-borne disease — approximately 30–40% of encephalitis cases are fatal. Of survivors, approximately 50–80% experience significant permanent neurological damage including cognitive impairment, personality changes, and physical disability. These outcomes are what make EEE particularly serious despite its relatively low incidence: it is rare, but when it strikes, the consequences are often severe or fatal. The combination of high mortality and severe survivor outcomes is why EEE receives significant concern relative to its incidence numbers.

The primary enzootic vector — responsible for bird-to-bird transmission — is Culiseta melanura, a species that breeds in freshwater hardwood swamps and feeds almost exclusively on birds. This bird-specific circulation amplifies the virus among avian populations. Bridge vectors that transmit EEE from birds to humans include several species from the genera Coquillettidia, Aedes, and Culex. These bridge vectors feed on both birds and mammals, creating the link between the enzootic cycle and human/horse exposure. In South Florida, the Everglades and connected freshwater wetlands support Culiseta melanura populations that feed into bridge vector transmission cycles.

Historically yes — northern and north-central Florida counties (particularly the Big Bend region and Atlantic coast swamplands) have produced the most frequent EEE clusters. The freshwater hardwood swamp habitat preferred by Culiseta melanura is more abundant in northern Florida. However, South Florida is not risk-free: EEE cases have been confirmed in Broward and Palm Beach counties, the Everglades supports the enzootic cycle, and bridge vector species are present throughout the region. South Florida's year-round warm temperatures mean the transmission season is longer than in northern states, potentially extending the window for sporadic EEE transmission events.

Yes — EEE affects horses severely, and 'Eastern Equine Encephalitis' is named in part because of its devastating effect on equines. Unvaccinated horses infected with EEE have a mortality rate of approximately 75–90%. Florida's equestrian communities (particularly in Broward, Palm Beach, and adjacent counties with horse farms) vaccinate horses against EEE routinely. EEE vaccination is standard equine veterinary care in Florida. Unlike humans, who have no approved vaccine, horses can be effectively protected against EEE with annual vaccination. Horse owners who notice neurological symptoms (stumbling, head pressing, seizures) in their animals after mosquito exposure should contact a veterinarian immediately.

EEE prevention combines personal protection with property-level mosquito reduction. Personal protection: use 25% DEET or 20% Picaridin during dawn and dusk periods, wear long-sleeved clothing in wooded or swampy areas, and limit outdoor activity during peak mosquito hours. Property-level protection: professional barrier spray reduces the adult mosquito population (including bridge vector species) in your yard's vegetation. Eliminating standing water reduces local breeding. For properties adjacent to freshwater wetlands, retention ponds, or swampy areas — which include many South Florida properties — the proximity to potential enzootic transmission cycles makes professional mosquito control a legitimate disease risk reduction measure.